Chicago, IL (PRWEB) September 13, 2013
The birth control safety advocates at DrugNews.net are announcing updated information for women who have taken the contraceptives Yaz or Yasmin. As the maker of the drugs has settled around 6,760 claims alleging blood clot injuries, the number of lawsuits has dropped slightly*.
DrugNews was designed to keep those patients taking popular prescription drugs updated with the latest research, safety alerts, recalls and legal news. Visitors can find out if others are experiencing similar side effects and decide if they need legal advice.
The resource center has added warnings from health experts like the British Medical Journal** and FDA*** that birth control pills containing the hormone drospirenone, like Yaz and Yasmin, can increase the risk of blood clots.
Due to the number of patients who have filed a Yaz lawsuit alleging side effects, cases were consolidated to a special federal Multi-District Litigation court in Illinois (Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois)).
DrugNews has added information showing drug maker Bayer has spent approximately $1.4 billion so far to settle around 6,760 claims alleging blood clot injuries like pulmonary embolism or deep vein thrombosis (DVT), and will continue to evaluate claims for settlement****.
Now, the resource center has learned the latest report from the Judicial Panel on Multidistrict Litigation shows the number of pending claims has fallen slightly from 9,998 on July 10 to 9,868 on August 15th*.
Anyone affected by blood clots, DVT, stroke or pulmonary embolism after taking Yaz or Yasmin can still learn their options by contacting the DrugNews Center or speaking with a lawyer.
Due to the complexity of federal MDL cases, patients should seek a lawyer with experience in defective drug litigation. DrugNews only recommends lawyers who have already settled Yaz lawsuits.
For more information on the research, side effects and litigation news related to Yaz and other drugs, or to speak with a lawyer, visit http://www.DrugNews.net.
*JPML 8/15/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL-Dockets_By_District-August-15-2013.pdf
**BMJ, 10/25/11; ncbi.nlm.nih.gov/pubmed/22027398
***FDA, 10/27/11, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf
****Bayer Stockholder’s Newsletter Q2, Explanatory Notes, Legal Risks, 7/31/13; stockholders-newsletter-q2-2013.bayer.com/en/explanatory-notes.aspx